睡眠呼吸暂停治疗对不明原因昏迷患者的影响:SINCOSAS研究
María-José Muñoz-Martínez1,2,3, Manuel Casal-Guisande2,4,5, Bernardo Sopeña3,6
1Pulmonary Department, Hospital Álvaro Cunqueiro, 36312 Vigo, Spain.
Journal of clinical medicine
|February 27, 2026
概括
在患有不明原因昏迷 (US) 的患者治疗睡眠呼吸暂停 (SA) 显著减少了昏发作和改善了心率变化. 这项研究突出了SA和US之间的联系,为管理昏迷患者提供了新的见解.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 自主神经科学 自主神经科学
背景情况:
- 无法解释的昏迷 (US) 是一个常见的临床挑战,通常与自主功能障碍有关.
- 睡眠呼吸暂停 (SA),以间歇性低氧症为特征,可能会加剧自主失衡,并导致US.
- 评估SA治疗对昏迷复发的影响对于患者管理至关重要.
研究的目的:
- 评估睡眠呼吸暂停治疗对未解释性昏迷患者昏迷复发的影响.
- 研究SA治疗对夜间心率变化 (HRV) 的影响.
- 为了评估在这个患者队列中SA治疗后生活质量的变化.
主要方法:
- 一项前性多中心研究,涉及美国成年人,他们接受了家庭呼吸道多重检测.
- 基于既定指导方针的SA诊断,治疗包括正气道压力,位置治疗和/或体重管理.
- 在基线和12个月随访时评估症状,昏迷负担,夜间HRV和生活质量 (SF-36,VAS).
主要成果:
- 在99名符合治疗标准的患者中,有67人完成了随访. 治疗SA显著降低了白天的嗜睡,疲劳,夜间的觉醒和同步期 (p < 0.001).
- 夜间HRV有所改善,由增加的RR间隔 (p < 0.001) 和RMSSD (p = 0.04) 表示.
- 生活质量有所改善,SF-36活力评分 (p = 0.02) 和视觉模拟尺度评分 (p = 0.002) 显著增加.
结论:
- 对于睡眠呼吸暂停的治疗,在不明原因昏迷的患者中,与昏迷复发的减少有关.
- 治疗SA对夜间HRV产生积极影响,并改善患者报告的疲劳和活力.
- 结果表明SA和US之间存在联系,但由于研究设计的局限性,需要在受控研究中确认.
相关概念视频
Sleep Apnea
641
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
641
Sleep-Wake Cycles
3.1K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.1K
Substance Use Disorders Affecting Sleep
484
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
484
Insufficient Sleep and Sleep Deprivation
1.0K
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
1.0K
Management of Insomnia
740
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
740
Heart Failure VI: Adjunct Therapies
466
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
466


